Global Synthetic Biology Market Size, Share, Forecast Report, 2020-2027

The global Synthetic Biology market garnered revenue around USD 4.98 Billion in 2019 and projected to reach USD 39.6 Billion in 2027, with at a compound annual growth rate (CAGR) 26.4% throughout the estimate period from 2020 to 2027.

Rise in prevalence of chronic conditions, such as cancer and diabetes, has increased the patient pool, followed by rise in demand for biologic drugs for treating various chronic conditions, resulting in boosting the growth of the synthetic biology market

In terms of product, the core product segment accounted for major share of the global synthetic biology market in 2019. The segment is anticipated to witness strong growth from 2019 to 2027.  The core product segment is further sub-segmented into synthetic DNA, synthetic genes, synthetic cells, XNA (xeno nucleic acid), and chassis organisms. The synthetic DNA sub-segment accounted for major share of the global synthetic biology market due to the increasing research & developmental activities associated to this sub-segment and increased penetration in the market.

The element that distinguishes synthetic biology from traditional molecular and cellular biology is the focus on the design and construction of core components (parts of enzymes, genetic circuits, and metabolic pathways) that can be understood, modeled, and tuned to meet specific performance criteria, and the assembly of these smaller parts and devices into bigger integrated systems for solving specific problems. These core components are formed through core products, such as synthetic genes and synthetic DNA.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Synthetic Biology market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Synthetic Biology market growth.

The global Synthetic Biology market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

the global synthetic biology market include Evolva, Amyris, Algenol, ATG:biosynthetics GmbH, Bayer AG, Bristol-Myers Squibb Company, BIONEER CORPORATION, Biosearch Technologies, BASF SE, Codexis, Ginkgo Bioworks, Integrated DNA Technologies, Inc., GenScript, Thermo Fisher Scientific, Eurofins Genomics LLC, OriGene Technologies, Inc., and DSM

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Synthetic Biology Market, by Tool

  • Oligonucleotides and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Synthetic Cells
  • Chassis Organisms
  • Xeno-nucleic Acids

Synthetic Biology Market, by Technology

  • Gene Synthesis
  • Genome Engineering
  • Cloning
  • Sequencing
  • Site-directed Mutagenesis
  • Measurement and Modeling
  • Microfluidics
  • Nanotechnology
  • Bioinformatics

Synthetic Biology Market, Application

  • Medical Application
  • Pharmaceuticals
  • Drug Discovery and Therapeutics
    • Cancer Detection & Diagnostics
    • Other Drug Discovery and Therapeutic Applications
  • Artificial Tissue and Tissue Regeneration
    • Bio-synthesis
    • Stem Cell Regulation
    • Other Tissue and Tissue Regeneration Applications
  • Industrial Applications
  • Biofuel and Renewable Energy
  • Biomaterials and Green Chemicals
  • Industrial Enzymes, by Application
    • Textile Industry
    • Paper Industry
    • Other Industries
  • Food & Agriculture
  • Environmental Applications
  • Bioremediation
  • Biosensing

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Rest of EU
  • Asia Pacific
    • China
    • India
    • Japan
    • Southeast Asia
    • Rest of APAC
  • Central & South America
    • Brazil
    • Argentina
    • Rest of Central & South America
  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • Rest of MEA